248 related articles for article (PubMed ID: 23590178)
1. Fighting obesity with a sugar-based library: discovery of novel MCH-1R antagonists by a new computational-VAST approach for exploration of GPCR binding sites.
Heifetz A; Barker O; Verquin G; Wimmer N; Meutermans W; Pal S; Law RJ; Whittaker M
J Chem Inf Model; 2013 May; 53(5):1084-99. PubMed ID: 23590178
[TBL] [Abstract][Full Text] [Related]
2. A virtual screening approach to finding novel and potent antagonists at the melanin-concentrating hormone 1 receptor.
Clark DE; Higgs C; Wren SP; Dyke HJ; Wong M; Norman D; Lockey PM; Roach AG
J Med Chem; 2004 Jul; 47(16):3962-71. PubMed ID: 15267235
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel diarylketoxime derivatives as selective and orally active melanin-concentrating hormone 1 receptor antagonists.
Suzuki T; Kameda M; Ando M; Miyazoe H; Sekino E; Ito S; Masutani K; Kamijo K; Takezawa A; Moriya M; Ito M; Ito J; Nakase K; Matsushita H; Ishihara A; Takenaga N; Tokita S; Kanatani A; Sato N; Fukami T
Bioorg Med Chem Lett; 2009 Sep; 19(18):5339-45. PubMed ID: 19683441
[TBL] [Abstract][Full Text] [Related]
4. Melanin concentrating hormone receptor 1 (MCHR1) antagonists-Still a viable approach for obesity treatment?
Högberg T; Frimurer TM; Sasmal PK
Bioorg Med Chem Lett; 2012 Oct; 22(19):6039-47. PubMed ID: 22954736
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel, orally available benzimidazoles as melanin concentrating hormone receptor 1 (MCHR1) antagonists.
Sasmal PK; Sasmal S; Rao PT; Venkatesham B; Roshaiah M; Abbineni C; Khanna I; Jadhav VP; Suresh J; Talwar R; Muzeeb S; Receveur JM; Frimurer TM; Rist Ø; Elster L; Högberg T
Bioorg Med Chem Lett; 2010 Sep; 20(18):5443-8. PubMed ID: 20724156
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening.
Cavasotto CN; Orry AJ; Murgolo NJ; Czarniecki MF; Kocsi SA; Hawes BE; O'Neill KA; Hine H; Burton MS; Voigt JH; Abagyan RA; Bayne ML; Monsma FJ
J Med Chem; 2008 Feb; 51(3):581-8. PubMed ID: 18198821
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel phenethylpyridone derivatives as potent melanin-concentrating hormone 1 receptor antagonists.
Ando M; Sekino E; Haga Y; Moriya M; Ito M; Ito J; Iwaasa H; Ishihara A; Kanatani A; Ohtake N
Bioorg Med Chem Lett; 2009 Sep; 19(17):5186-90. PubMed ID: 19632840
[TBL] [Abstract][Full Text] [Related]
8. Discovery of 1,3-disubstituted-1H-pyrrole derivatives as potent melanin-concentrating hormone receptor 1 (MCH-R1) antagonists.
Berglund S; Egner BJ; Gradén H; Gradén J; Morgan DG; Inghardt T; Giordanetto F
Bioorg Med Chem Lett; 2008 Sep; 18(17):4859-63. PubMed ID: 18682323
[TBL] [Abstract][Full Text] [Related]
9. An example of designed multiple ligands spanning protein classes: dual MCH-1R antagonists/DPPIV inhibitors.
Gattrell WT; Sambrook Smith CP; Smith AJ
Bioorg Med Chem Lett; 2012 Apr; 22(7):2464-9. PubMed ID: 22377519
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel spiro-piperidine derivatives as highly potent and selective melanin-concentrating hormone 1 receptor antagonists.
Suzuki T; Moriya M; Sakamoto T; Suga T; Kishino H; Takahashi H; Ishikawa M; Nagai K; Imai Y; Sekino E; Ito M; Iwaasa H; Ishihara A; Tokita S; Kanatani A; Sato N; Fukami T
Bioorg Med Chem Lett; 2009 Jun; 19(11):3072-7. PubMed ID: 19403308
[TBL] [Abstract][Full Text] [Related]
11. Computer-aided identification of ligands for GPCR anti-obesity targets.
Min KH; Yoo J; Park HJ
Curr Top Med Chem; 2009; 9(6):539-53. PubMed ID: 19689364
[TBL] [Abstract][Full Text] [Related]
12. Solid-phase synthesis and structure-activity relationships of novel biarylethers as melanin-concentrating hormone receptor-1 antagonists.
Ma V; Bannon AW; Baumgartner J; Hale C; Hsieh F; Hulme C; Rorrer K; Salon J; van Staden C; Tempest P
Bioorg Med Chem Lett; 2006 Oct; 16(19):5066-72. PubMed ID: 16887348
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity.
Kowalski TJ; McBriar MD
Expert Opin Investig Drugs; 2004 Sep; 13(9):1113-22. PubMed ID: 15330743
[TBL] [Abstract][Full Text] [Related]
14. Prospects for obesity treatment: MCH receptor antagonists.
Collins CA; Kym PR
Curr Opin Investig Drugs; 2003 Apr; 4(4):386-94. PubMed ID: 12808876
[TBL] [Abstract][Full Text] [Related]
15. Discovery of orally efficacious melanin-concentrating hormone receptor-1 antagonists as antiobesity agents. Synthesis, SAR, and biological evaluation of bicyclo[3.1.0]hexyl ureas.
McBriar MD; Guzik H; Shapiro S; Paruchova J; Xu R; Palani A; Clader JW; Cox K; Greenlee WJ; Hawes BE; Kowalski TJ; O'neill K; Spar BD; Weig B; Weston DJ; Farley C; Cook J
J Med Chem; 2006 Apr; 49(7):2294-310. PubMed ID: 16570926
[TBL] [Abstract][Full Text] [Related]
16. Novel aminobenzimidazoles as selective MCH-R1 antagonists for the treatment of metabolic diseases.
Sasikumar TK; Qiang L; Burnett DA; Greenlee WJ; Hawes BE; Kowalski TJ; O'Neill K; Spar BD; Weig B
Bioorg Med Chem Lett; 2006 Oct; 16(20):5427-31. PubMed ID: 16889961
[TBL] [Abstract][Full Text] [Related]
17. Building a MCHR1 homology model provides insight into the receptor-antagonist contacts that are important for the development of new anti-obesity agents.
Cirauqui N; Schrey AK; Galiano S; Ceras J; Pérez-Silanes S; Aldana I; Monge A; Kühne R
Bioorg Med Chem; 2010 Nov; 18(21):7365-79. PubMed ID: 20932767
[TBL] [Abstract][Full Text] [Related]
18. Antiobesity effects of melanin-concentrating hormone receptor 1 (MCH-R1) antagonists.
Cheon HG
Handb Exp Pharmacol; 2012; (209):383-403. PubMed ID: 22249825
[TBL] [Abstract][Full Text] [Related]
19. 6-(4-chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-based melanin-concentrating hormone receptor 1 antagonist.
Tavares FX; Al-Barazanji KA; Bishop MJ; Britt CS; Carlton DL; Cooper JP; Feldman PL; Garrido DM; Goetz AS; Grizzle MK; Hertzog DL; Ignar DM; Lang DG; McIntyre MS; Ott RJ; Peat AJ; Zhou HQ
J Med Chem; 2006 Nov; 49(24):7108-18. PubMed ID: 17125263
[TBL] [Abstract][Full Text] [Related]
20. Promising strategies for obesity pharmacotherapy: melanocortin-4 (MC-4) receptor agonists and melanin concentrating hormone (MCH) receptor-1 antagonists.
Jeon MK; Cheon HG
Curr Top Med Chem; 2009; 9(6):504-38. PubMed ID: 19689363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
